Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation
Recognizing an increasing need for biomarkers that predict clinical outcomes in type 1 diabetes (T1D), JDRF, a major funding organization for T1D research, recently instituted the Core for Assay Validation (CAV) to accelerate the translation of promising assays from discovery to clinical implementat...
Main Authors: | Cate Speake, Jared M. Odegard |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-01-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.4137/BMI.S29697 |
Similar Items
-
Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation
by: Cate Speake, et al.
Published: (2015-09-01) -
The development and implementation of a TMT-SRM assay for the validation of candidate biomarkers of Alzheimer's disease
by: O'Brien, Darragh
Published: (2011) -
Proteomic analysis to identify candidate biomarkers associated with type 1 diabetes
by: do Nascimento de Oliveira V, et al.
Published: (2018-06-01) -
Candidate Glycoprotein Biomarkers for Canine Visceral Hemangiosarcoma and Validation Using Semi-Quantitative Lectin/Immunohistochemical Assays
by: Patharee Oungsakul, et al.
Published: (2021-02-01) -
Verification of the Bladder Cancer Biomarker Candidates by SISCAPA-MRM Assay
by: Meng Kai Chou, et al.
Published: (2017)